Search
for
Sort by
Research 61–90 of 584
- Small Molecule Inhibitors and Inflammatory Skin Diseases
- INVESTIGATING THE MECHANISMS UNDERLYING THE PATHOGENESIS OF ALOPECIA AREATA
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)
- JAK1 Signaling Is Involved in the Induction of Mechanical Alloknesis in Atopic Dermatitis
- Baricitinib as a treatment for myasthenia gravis: A case report
- Could baricitinib treat frontal fibrosing alopecia and facial papules?
- Ruxolitinib found to cause eyelash growth: a case report
- Anticancer Effects of Cepharanthine: an Updated Minireview
- Down‐regulation of Shh in the hair follicles of mice during chemotherapy‐induced hair loss is mediated by the JAK / STAT1 signaling pathway
- P718 Observational real-world evidence on the efficacy and safety of Janus Kinase inhibitors (JAKi) in the treatment of moderate to severe Active Ulcerative Colitis (UC)
- Extensive alopecia areata is reversed by IL-12/IL-23p40 cytokine antagonism
- Treatment of alopecia universalis with topical Janus kinase inhibitors – a double blind, placebo, and active controlled pilot study
- Hair cycle control by leptin as a new anagen inducer
- Leptin controls hair follicle cycling
- Various Applications of Tofacitinib and Ruxolitinib (Janus Kinase Inhibitors) in Dermatology and Rheumatology: A Review of Current Evidence and Future Perspective
- Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review
- Effect of tofacitinib on the expression of noggin/BMP-4 and hair growth stimulation in mice
- Role of topical tofacitinib in autoimmune skin disorders: An expert opinion
- Upadacitinib in the treatment of a patient with the triad of atopic dermatitis, vitiligo, and alopecia areata: a case report and literature review
- Upadacitinib in dermatologic therapy: Emerging evidence and expanding indications
- Case Series and Literature Review on Tofacitinib for Treating Severe Alopecia Areata
- Baricitinib for the Treatment of Moderate-to-Severe Alopecia Areata
- Ritlecitinib in severe alopecia areata: a profile of its use
- Effects of the RV3466F lotion on female telogen effluvium: Results from a 16 week, multi-centric, controlled, randomized trial
- Molecular Dissection of Mesenchymal–Epithelial Interactions in the Hair Follicle
- Alopecia areata
- Age-associated inflammation inhibits epidermal stem cell function
- Human Scalp Hair Follicles Are Both a Target and a Source of Prolactin, which Serves as an Autocrine and/or Paracrine Promoter of Apoptosis-Driven Hair Follicle Regression
- Oxidative stress in ageing of hair
- Prolactin and the Skin: A Dermatological Perspective on an Ancient Pleiotropic Peptide Hormone